They actually stopped trials for liver disease midway as they found a cure for sorosis of the liver. Very rare to have success that quick and it was not expected for the treatment of this (trials). Low estimate of 5 Billion a year revenue. Crazy stuff. Clovis (CLVS) is making progress with Lung Cancer treatment. I use to trade a lot of Biotech stocks before I went into SKUL..
Investing in biotechs is kinda like playing high stakes poker.... Either gonna come out a rich man or your gonna lose it all..... Clovis is a very interesting company . My favorite in that space ( there a lot more than biotech ) is intrexon led by Randall Kirk. He's a legend in biotech space. I almost bought a boatload around 20 a few weeks back but didn't pull the trigger ( 30 now) . Still may get some in the coming months but they are gonna be huge winner long term. Anyhow looking forward to hoby presentation Monday. Like my earlier post .... I rarely invest in turnaround stories..... But I have no doubt with hoby leading skullcandy ..... It's gonna be a fun next few years to see this thing turn into a cash machine